Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMC 3657522)

Published in Clin Infect Dis on June 14, 2012

Authors

Christopher R Polage1, Jay V Solnick, Stuart H Cohen

Author Affiliations

1: Department of Pathology and Laboratory Medicine, Division of Infectious Diseases, University of California, Davis Medical Center, Sacramento, USA. christopher.polage@ucdmc.ucdavis.edu

Articles citing this

Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era. JAMA Intern Med (2015) 5.04

Genotypes of Klebsiella oxytoca isolates from patients with nosocomial pneumonia are distinct from those of isolates from patients with antibiotic-associated hemorrhagic colitis. J Clin Microbiol (2014) 0.93

Comparison of Simplexa universal direct PCR with cytotoxicity assay for diagnosis of Clostridium difficile infection: performance, cost, and correlation with disease. J Clin Microbiol (2013) 0.86

Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications. BMC Infect Dis (2015) 0.82

Doxycycline and Tigecycline: Two Friendly Drugs with a Low Association with Clostridium Difficile Infection. Antibiotics (Basel) (2015) 0.81

The HtrA-like protease CD3284 modulates virulence of Clostridium difficile. Infect Immun (2014) 0.77

Hospital acquired diarrhea in a burn center of Tehran. Iran J Microbiol (2015) 0.75

Clostridium difficile Infections in Medical Intensive Care Units of a Medical Center in Southern Taiwan: Variable Seasonality and Disease Severity. PLoS One (2016) 0.75

Outcomes and Risk Factors Associated with Clostridium difficile Diarrhea in Hospitalized Adult Patients. Gastroenterol Res Pract (2015) 0.75

Draft Genome Sequence of Clostridium butyricum Strain NOR 33234, Isolated from an Elderly Patient with Diarrhea. Genome Announc (2014) 0.75

Point-Counterpoint: What is the optimal approach for detection of Clostridium difficile infection? J Clin Microbiol (2017) 0.75

Reactivated cytomegalovirus proctitis in an immunocompetent patient presenting as nosocomial diarrhea: a case report and literature review. BMC Infect Dis (2017) 0.75

Novel portable platform for molecular detection of toxigenic Clostridium difficile in faeces: a diagnostic accuracy study. Eur J Clin Microbiol Infect Dis (2016) 0.75

Articles cited by this

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol (2010) 17.99

Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med (2007) 9.44

Norovirus gastroenteritis. N Engl J Med (2009) 7.66

Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol (2004) 4.46

Clinical manifestation of norovirus gastroenteritis in health care settings. Clin Infect Dis (2004) 2.50

Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis. N Engl J Med (2006) 2.33

Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis (1994) 2.29

Epidemiology and cost of nosocomial gastroenteritis, Avon, England, 2002-2003. Emerg Infect Dis (2004) 2.16

Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin Microbiol Rev (2009) 2.09

Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognized cause of morbidity. Clin Infect Dis (2009) 2.04

Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study. Am J Transplant (2011) 1.75

Diarrhea in liver transplant recipients: etiology and management. Liver Transpl (2005) 1.71

Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea. Best Pract Res Clin Gastroenterol (2004) 1.54

Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA (2001) 1.53

Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology (1994) 1.51

The intestinal microbiota in health and disease. Curr Opin Gastroenterol (2012) 1.43

Epidemiology of infectious and iatrogenic nosocomial diarrhea in a cohort of general medicine patients. Am J Infect Control (1995) 1.35

Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management. Ther Adv Med Oncol (2010) 1.33

Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus. J Clin Microbiol (2006) 1.31

Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm? Bone Marrow Transplant (2008) 1.23

Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality. Am J Kidney Dis (2008) 1.20

Role of Klebsiella oxytoca in antibiotic-associated diarrhea. Clin Infect Dis (2008) 1.18

Nosocomial antibiotic-associated diarrhea associated with enterotoxin-producing strains of methicillin-resistant Staphylococcus aureus. Am J Gastroenterol (2005) 1.17

Laboratory diagnosis of Clostridium perfringens antibiotic-associated diarrhoea. J Med Microbiol (2002) 1.15

Safety of probiotics: translocation and infection. Nutr Rev (2008) 1.13

The gut microbiota predispose to the pathophysiology of acute postradiotherapy diarrhea. Am J Gastroenterol (2008) 1.11

Colon ischemia: recent insights and advances. Curr Gastroenterol Rep (2010) 1.11

Infectious diarrhea due to Clostridium perfringens. J Infect Dis (1988) 1.09

Severe diarrhea in renal transplant patients: results of the DIDACT study. Am J Transplant (2006) 1.06

Nosocomial Rotavirus Gastroenteritis in pediatric patients: a multi-center prospective cohort study. BMC Infect Dis (2010) 1.03

Diarrhoea in the critically ill. Curr Opin Crit Care (2006) 1.02

Evidence for antibiotic induced Clostridium perfringens diarrhoea. J Clin Pathol (2001) 1.01

The incidence of viral-associated diarrhea after admission to a pediatric hospital. Am J Epidemiol (1990) 0.99

Drug-induced diarrhoea. Drug Saf (2000) 0.99

Synbiotics and probiotics in the critically ill after the PROPATRIA trial. Curr Opin Clin Nutr Metab Care (2012) 0.98

Study of diarrhea in critically ill patients. Crit Care Med (1983) 0.96

Diarrhea in neutropenic patients: a prospective cohort study with emphasis on neutropenic enterocolitis. Ann Oncol (2006) 0.93

Fecal leukocyte stain has diagnostic value for outpatients but not inpatients. J Clin Microbiol (2001) 0.91

Mechanisms, prevention, and management of diarrhea in enteral nutrition. Curr Opin Gastroenterol (2011) 0.91

Clostridium difficile infection in solid organ transplant recipients. Curr Opin Organ Transplant (2008) 0.89

Gastrointestinal toxicity and Clostridium difficile diarrhea in patients treated with paclitaxel-containing chemotherapy regimens. Gynecol Oncol (1998) 0.87

Drug-induced diarrhea. Curr Gastroenterol Rep (2007) 0.86

Prevalence of enterotoxin producing Staphylococcus aureus in stools of patients with nosocomial diarrhea. Infection (2007) 0.86

Diarrhea in the intensive care patient. Crit Care Clin (1995) 0.86

Prevalence of Clostridium difficile toxins A and B and Clostridium perfringens enterotoxin A in stool samples of patients with antibiotic-associated diarrhea. Infection (2005) 0.85

Work-up for infectious diarrhea after allogeneic hematopoietic stem cell transplantation: single specimen testing results in cost savings without compromising diagnostic yield. Transpl Infect Dis (2007) 0.83

A retrospective cohort study of nosocomial diarrhea as a risk factor for nosocomial infection. J Infect Dis (1990) 0.82

Norovirus infection as a cause of sporadic healthcare-associated diarrhoea. J Hosp Infect (2009) 0.81

A study of the prevalence of cytotoxic and non-cytotoxic Klebsiella oxytoca fecal colonization in two patient populations. Can J Infect Dis Med Microbiol (2009) 0.81

Prevalence of diarrhea at a university hospital and association with modifiable risk factors. Ann Pharmacother (2006) 0.78

The pathophysiology of diarrhea. Clin Transplant (2001) 0.77

Articles by these authors

Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe (2009) 4.20

Amphotericin B: time for a new "gold standard". Clin Infect Dis (2003) 4.01

Functional plasticity in the type IV secretion system of Helicobacter pylori. PLoS Pathog (2013) 1.84

Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection. Blood (2012) 1.68

Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California. J Clin Microbiol (2006) 1.65

From bench to bedside: stealth of enteroinvasive pathogens. Nat Rev Microbiol (2008) 1.58

Infection with Helicobacter pylori is associated with protection against tuberculosis. PLoS One (2010) 1.45

Helicobacter pylori AddAB helicase-nuclease and RecA promote recombination-related DNA repair and survival during stomach colonization. Mol Microbiol (2008) 1.33

Description of 'Candidatus Helicobacter heilmannii' based on DNA sequence analysis of 16S rRNA and urease genes. Int J Syst Evol Microbiol (2004) 1.31

Genotypic profile of the outer membrane proteins BabA and BabB in clinical isolates of Helicobacter pylori. Infect Immun (2006) 1.29

Expression of the BabA adhesin during experimental infection with Helicobacter pylori. Infect Immun (2010) 1.26

Helicobacter pylori induces an antimicrobial response in rhesus macaques in a cag pathogenicity island-dependent manner. Gastroenterology (2008) 1.21

Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent clostridium difficile-associated diarrhea. J Clin Microbiol (2003) 1.19

Spatial and temporal analysis of Clostridium difficile infection in patients at a pediatric hospital in California. Infect Control Hosp Epidemiol (2005) 1.11

The role of genome diversity and immune evasion in persistent infection with Helicobacter pylori. FEMS Immunol Med Microbiol (2005) 1.08

Evaluation of Clostridium difficile fecal load and limit of detection during a prospective comparison of two molecular tests, the illumigene C. difficile and Xpert C. difficile/Epi tests. J Clin Microbiol (2012) 1.07

Comparison of Helicobacter pylori virulence gene expression in vitro and in the Rhesus macaque. Infect Immun (2005) 1.06

Captive rhesus monkeys (Macaca mulatta) are commonly infected with Helicobacter cinaedi. J Clin Microbiol (2002) 1.05

Inflammation, immunity, and vaccine development for Helicobacter pylori. Helicobacter (2011) 1.05

Outcomes in patients tested for Clostridium difficile toxins. Diagn Microbiol Infect Dis (2012) 1.03

Modification of gastric mucin oligosaccharide expression in rhesus macaques after infection with Helicobacter pylori. Gastroenterology (2009) 0.99

Epidemiologic surveillance of Clostridium difficile diarrhea in a freestanding pediatric hospital and a pediatric hospital at a university medical center. Diagn Microbiol Infect Dis (2006) 0.96

Gastric transcription profile of Helicobacter pylori infection in the rhesus macaque. Infect Immun (2004) 0.95

Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: an assessment of currently available triazoles. Antimicrob Agents Chemother (2011) 0.94

Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile. J Antimicrob Chemother (2003) 0.94

Life at the margins: modulation of attachment proteins in Helicobacter pylori. Gut Microbes (2011) 0.93

Early treatment with fluconazole may abrogate the development of IgG antibodies in coccidioidomycosis. Clin Infect Dis (2011) 0.91

Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice. Vaccine (2006) 0.91

Transcription profile of Helicobacter pylori in the human stomach reflects its physiology in vivo. J Infect Dis (2004) 0.91

Effects of a Th1- versus a Th2-biased immune response in protection against Helicobacter pylori challenge in mice. Microb Pathog (2007) 0.90

The impact of Helicobacter pylori infection on the gastric microbiota of the rhesus macaque. PLoS One (2013) 0.88

Quantitation of H. pylori cytotoxin mRNA by real-time RT-PCR shows a wide expression range that does not correlate with promoter sequences. Microb Pathog (2004) 0.88

Treatments for hepatitis B. Clin Infect Dis (2004) 0.88

Serum glycan signatures of gastric cancer. Cancer Prev Res (Phila) (2013) 0.88

Derivation and validation of a clinical prediction score for isolation of inpatients with suspected pulmonary tuberculosis. Infect Control Hosp Epidemiol (2008) 0.86

Inhibition of heat shock protein expression by Helicobacter pylori. Microb Pathog (2009) 0.86

In vivo expression of Helicobacter pylori virulence genes in patients with gastritis, ulcer, and gastric cancer. Infect Immun (2011) 0.86

Clindamycin resistant strains of Clostridium difficile isolated from cases of C. difficile associated diarrhea (CDAD) in a hospital in Sweden. Diagn Microbiol Infect Dis (2002) 0.85

Hepatic mucormycosis with abscess formation. Diagn Microbiol Infect Dis (2012) 0.85

Novel gastric helicobacters and oral campylobacters are present in captive and wild cetaceans. Vet Microbiol (2011) 0.84

Possible correlates of long-term protection against Helicobacter pylori following systemic or combinations of mucosal and systemic immunizations. Infect Immun (2007) 0.84

Conserved transcriptional unit organization of the cag pathogenicity island among Helicobacter pylori strains. Front Cell Infect Microbiol (2012) 0.84

Serum (1->3)-β-D-glucan measurement in coccidioidomycosis. J Clin Microbiol (2012) 0.83

Analysis of Clostridium difficile-associated diarrhea among patients hospitalized in tertiary care academic hospital. Diagn Microbiol Infect Dis (2005) 0.83

Isolation of non-toxigenic strains of Clostridium difficile from cases of diarrhea among patients hospitalized in hematology/oncology ward. Pol J Microbiol (2004) 0.83

Injecting drug use and community-associated methicillin-resistant Staphylococcus aureus infection. Diagn Microbiol Infect Dis (2008) 0.83

The continuing saga of MRSA. J Infect Dis (2008) 0.82

Predicting the outcome of infectious diseases: variability among inbred mice as a new and powerful tool for biomarker discovery. MBio (2012) 0.82

Prevalence of the ermB gene in Clostridium difficile strains isolated at a university teaching hospital from 1987 through 1998. Clin Infect Dis (2005) 0.78

Environmental determinants of transformation efficiency in Helicobacter pylori. J Bacteriol (2013) 0.78

Association between serum 25-hydroxyvitamin D level and type of coccidioidal infection. Med Mycol (2012) 0.77

Method for profiling mucin oligosaccharides from gastric biopsies of rhesus monkeys with and without Helicobacter pylori infection. Anal Chem (2007) 0.76

Coccidioidomycosis: adenosine deaminase levels, serologic parameters, culture results, and polymerase chain reaction testing in pleural fluid. Chest (2013) 0.75

Treatment with moxifloxacin versus standard therapy for community-acquired pneumonia. Clin Infect Dis (2006) 0.75

Treatment of cytomegalovirus retinitis with cytomegalovirus-specific T-lymphocyte infusion. Ophthalmic Surg Lasers Imaging Retina (2015) 0.75

Apoptosis of gastric lymphocytes in Helicobacter pylori-infected rhesus macaques. Dig Dis Sci (2003) 0.75

Cutaneous manifestations of infection in returning travelers. Curr Infect Dis Rep (2014) 0.75

Meeting report: a symposium on the evolution of common molecular pathways underlying innate immunity. Microbes Infect (2012) 0.75

Teaching neuroimages: fungus in the brain: coccidioidomycosis meningoencephalitis. Neurology (2013) 0.75